US 10023862
Organic compositions to treat beta-catenin-related diseases
granted A61KA61K31/713A61P
Quick answer
US patent 10023862 (Organic compositions to treat beta-catenin-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/713, A61P, A61P17/02, A61P19/10